Oatworks is a beverage based on fruit purées and concentrates, and oat beta-glucan.
Oat ingredients supplier Biovelop (Kimstad, Sweden) continues to reinvent the way consumers eat oats. Having already supplied oat protein (prOATein) and soluble oat fiber (PromOat) for some time, the company's oat fiber is now in Oatworks, a branded oat beverage.
Right now, Oatworks is available in three flavors based around fruit purées and concentrates, but the functional benefit of the drink revolves around its added oat fiber-equal to the fiber content of two bowls of oatmeal. Soluble oat fiber is rich in beta-glucan, and research points to potential cholesterol reduction following consumption of this compound. The evidence is substantial enough that FDA, EFSA, and Health Canada have all approved health claims for oat fiber or oat beta-glucan and lowering risk of heart disease by lowering cholesterol.
David Peters, CEO of Wellness Works, which manufactures the product, adds that the beverage may also promote satiety and sustained energy.
“Oatworks addresses the need from busy consumers to enjoy a convenient, nutrient-rich breakfast on the go,” said Peters in an official press statement. “Our oat-powered smoothies combine the well-recognized health benefits of oats with real fruit, to create a delicious and genuinely healthy ‘snackfast.’ They are also the perfect way to extend the appeal of oatmeal beyond breakfast throughout the day.”
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.